Articles dans des revues avec comité de lecture (149)
33.
Sarracino, A., Gharu, L., Kula, A., Pasternak, A., Avettand-Fenoel, V., Rouzioux, C., Bardina, M., De Wit, S., Benkirane, M., Berkhout, B., Van Lint, C., & Marcello, A. (2018). Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3. MBio, 9(6). doi:10.1128/mBio.02158-1834.
Collignon, E., Canale, A., Al Wardi, C., Bizet, M., Calonne, E., Dedeurwaerder, S., Garaud, S., Naveaux, C., Barham, W., Wilson, A., Bouchat, S., Hubert, P., Van Lint, C., Yull, F., Sotiriou, C., Willard-Gallo, K., Noël, A., & Fuks, F. (2018). Immunity drives TET1 regulation in cancer through NF-kB. Science advances, 4(6), eaap7309. doi:10.1126/sciadv.aap730935.
El Khoury, G., Darcis, G., Lee, M., Bouchat, S., Van Driessche, B., Purcell, D., & Van Lint, C. (2018). The Molecular Biology of HIV Latency. Advances in experimental medicine and biology, 1075, 187-212. doi:10.1007/978-981-13-0484-2_837.
Fauquenoy, S., Robette, G., Kula, A., Vanhulle, C., Bouchat, S., Delacourt, N., Rodari, A., Marban, C., Schwartz, C., Burny, A., Rohr, O., Van Driessche, B., & Van Lint, C. (2017). Repression of Human T-lymphotropic virus type 1 Long Terminal Repeat sense transcription by Sp1 recruitment to novel Sp1 binding sites. Scientific reports, 7, 43221. doi:10.1038/srep4322138.
Passaes, C. P. B., Bruel, T., Decalf, J., David, A., Angin, M., Monceaux, V., Muller-Trutwin, M., Noel, N., Bourdic, K., Lambotte, O., Albert, M., Duffy, D., Schwartz, O., Sáez-Cirión, A., ANRS RHIVIERA, C., Barré-Sinoussi, F., Rouzioux, C., Autran, B., Benkirane, M., Guedj, J., Hocqueloux, L., Katlama, C., Legrand, R., Meyer, L., Mouquet, H., Taburet, A. M., Van Lint, C., & Delfraissy, J. (2017). Ultrasensitive HIV-1 p24 assay detects single infected cells and differences in reservoir induction by latency reversal agents. Journal of virology, 91(6), e02296-16. doi:10.1128/JVI.02296-1639.
Schwartz, C., Bouchat, S., Marban, C., Gautier, V., Van Lint, C., Rohr, O., & Le Douce, V. (2017). On the way to find a cure: Purging latent HIV-1 reservoirs. Biochemical pharmacology, 146, 10-22. doi:10.1016/j.bcp.2017.07.00140.
Gama, L., Pianowski, L. F., Haase, A., Van Lint, C., Siliciano, R., Abreu, C. M., Shirk, E., Price, S. S., Li, M., Laird, G. G., Pate, K. A. M., Wietgrefe, S., & O'connor, S. (2017). Reactivation of simian immunodeficiency virus reservoirs in the brain of virally suppressed macaques. AIDS, 31(1), 5-14. doi:10.1097/QAD.000000000000126741.
Darcis, G., Bouchat, S., Kula, A., Van Driessche, B., Delacourt, N., Vanhulle, C., Avettand-Fenoel, V., De Wit, S., Rohr, O., Rouzioux, C., & Van Lint, C. (2017). Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir. AIDS, 31(2), 181-189. doi:10.1097/QAD.000000000000129042.
Hotter, D., Krabbe, T., Reith, E., Gawanbacht, A., Rahm, N., Ayouba, A., Van Lint, C., Peeters, M., & Kirchhoff, F. (2017). Primate lentiviruses use at least three alternative strategies to suppress NF-κB-mediated immune activation. P L o S Pathogens, 13(8), e1006598. doi:10.1371/journal.ppat.100659844.
Le Douce, V., Forouzanfard, F., Eilebrecht, S., Van Driessche, B., Ait-Ammar, A., Verdikt, R., Kurashige, Y., Marban, C., Gautier, V., Candolfi, E., Benecke, A., Van Lint, C., Rohr, O., & Schwartz, C. (2016). HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1 (C. Van Lint, O. Rohr and C. Schwartz are co-last authors). Scientific Reports, 6, 34920. doi:10.1038/srep34920